Skip to main content
. 2017 Jul;18(7):929–945. doi: 10.1016/S1470-2045(17)30404-7

Figure 1.

Figure 1

Trial profile

E=standard epirubicin. aE=accelerated epirubicin. CMF=cyclophosphamide, methotrexate, and fluorouracil. X=capecitabine. ITT=intention-to-treat. *Per-protocol population.